Abstract |
A two-compound ointment containing calcipotriol plus betamethasone dipropionate is an effective treatment for psoriasis vulgaris. The same active ingredients have now been combined in a gel formulation. Our objective was to compare the efficacy and safety of once daily treatment of the two-compound gel with the single components in the same gel vehicle and the gel vehicle alone, in patients with psoriasis vulgaris on the trunk and/or limbs. 364 patients received once daily treatment for up to 8 weeks with either the two-compound gel, the single components in the gel vehicle or the gel vehicle alone. The percentage of patients whose disease was clear or very mild and who had at least a two-step improvement in the Investigator's Global Assessment of disease severity at week 8, was significantly higher with calcipotriol plus betamethasone dipropionate (27.2%) than with betamethasone dipropionate (16.9%, p = 0.027), calcipotriol (11.4%, p = 0.006) or gel vehicle (0.0%, p < 0.001). This exploratory study showed that the two-compound gel was safe and more efficacious than its individual ingredients in the treatment of psoriasis vulgaris.
|
Authors | Colin Fleming, Cecilia Ganslandt, Lyn Guenther, Anders Johannesson, Colin Buckley, Jan C Simon, Helen Stegmann, Lotte Vestergaard Tingleff |
Journal | European journal of dermatology : EJD
(Eur J Dermatol)
2010 Jul-Aug
Vol. 20
Issue 4
Pg. 465-71
ISSN: 1167-1122 [Print] France |
PMID | 20413372
(Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Inflammatory Agents
- Dermatologic Agents
- Drug Combinations
- Gels
- Immunoglobulin A
- Ointments
- Pharmaceutical Vehicles
- calcipotriene
- Betamethasone
- Calcitriol
|
Topics |
- Administration, Topical
- Analysis of Variance
- Anti-Inflammatory Agents
(administration & dosage, therapeutic use)
- Betamethasone
(administration & dosage, therapeutic use)
- Calcitriol
(administration & dosage, analogs & derivatives, therapeutic use)
- Dermatologic Agents
(administration & dosage, therapeutic use)
- Double-Blind Method
- Drug Combinations
- Europe
- Female
- Gels
- Humans
- Immunoglobulin A
(blood)
- Male
- Middle Aged
- Ointments
- Pharmaceutical Vehicles
- Prospective Studies
- Psoriasis
(drug therapy)
- Severity of Illness Index
- Treatment Outcome
|